Literature DB >> 15774498

Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter.

Armina A Kazi1, Jenny M Jones, Robert D Koos.   

Abstract

Vascular endothelial growth factor (VEGF) plays a pivotal role in the regulation of microvascular permeability and angiogenesis, processes essential for normal endometrial growth and implantation. Estrogen [17beta-estradiol (E2)], via its receptor (ER alpha), rapidly stimulates VEGF expression in the uterus at the transcriptional level. The VEGF gene promoter, however, lacks a consensus estrogen response element (ERE), and attempts to identify the site through which E2 induces VEGF expression have yielded contradictory results. To address this question, we modified the chromatin immunoprecipitation method to identify transcription factors that interact with the VEGF promoter in the rat uterus in response to E2. Chromatin immunoprecipitation showed that both Sp1 and Sp3 were associated with a proximal, GC-rich region of the promoter before E2 treatment. E2 induced an increase in Sp1 binding and the recruitment of ER alpha, and the coactivator p300 to this region. The association of ER alpha persisted, however, after VEGF mRNA levels had declined again (at 4 h), indicating that other factors might be involved in that expression. Western analysis showed that both the alpha- and beta-subunits of the transcription factor hypoxia-inducible factor 1 (HIF-1), which regulates VEGF expression in response to hypoxia and several hormones and growth factors, were present in the uterus. Furthermore, E2 rapidly induced their recruitment to the -944 to -611 bp region of the VEGF promoter, which contains the hypoxia response element to which HIF-1 binds. This binding was transient, matching the pattern of E2-induced VEGF expression. These results indicate that HIF-1 is an important mediator of E2-induced VEGF expression in the uterus. In addition, E2 also induced a later increase in HIF-1alpha mRNA and protein expression in the uterus, suggesting that it may be required for longer term effects of E2 on the uterus as well. In contrast to the uterus, HEC1A cells cultured in 95% air-5% CO2 (and therefore 20% O2) contained no HIF-1alpha, consistent with the inability of E2 to stimulate the expression of VEGF by these and other cell types in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774498     DOI: 10.1210/me.2004-0388

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  42 in total

Review 1.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

Review 2.  Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy.

Authors:  Eugene D Albrecht; Gerald J Pepe
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 3.  Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.

Authors:  Bonnie J Deroo; Adrian V Buensuceso
Journal:  Mol Endocrinol       Date:  2010-04-02

4.  HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.

Authors:  Gauri J Sabnis; Olga G Goloubeva; Armina A Kazi; Preeti Shah; Angela H Brodie
Journal:  Mol Cancer Ther       Date:  2013-10-03       Impact factor: 6.261

5.  Aromatase resistance mechanisms in model systems in vivo.

Authors:  Angela Brodie; Luciana Macedo; Gauri Sabnis
Journal:  J Steroid Biochem Mol Biol       Date:  2009-09-22       Impact factor: 4.292

6.  Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy.

Authors:  Thomas W Bonagura; Gerald J Pepe; Allen C Enders; Eugene D Albrecht
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

7.  HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.

Authors:  N Ogba; Y Q Doughman; L J Chaplin; Y Hu; M Gargesha; M Watanabe; M M Montano
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

8.  Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

Authors:  Maura N Dickler; William T Barry; Constance T Cirrincione; Matthew J Ellis; Mary Ellen Moynahan; Federico Innocenti; Arti Hurria; Hope S Rugo; Diana E Lake; Olwen Hahn; Bryan P Schneider; Debasish Tripathy; Lisa A Carey; Eric P Winer; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2016-05-02       Impact factor: 44.544

9.  Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy.

Authors:  Eugene D Albrecht; Jeffery S Babischkin; Gerald J Pepe
Journal:  Mol Reprod Dev       Date:  2008-03       Impact factor: 2.609

10.  Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis.

Authors:  Tongfeng Zhao; Jing Lv; Jiangpei Zhao; Marius Nzekebaloudou
Journal:  J Exp Clin Cancer Res       Date:  2009-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.